CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans
2006

CXCL12 Binding in Rheumatoid Arthritis Endothelial Cells

Sample size: 9 publication 10 minutes Evidence: moderate

Author Information

Author(s): Santiago Begoña, Baleux Françoise, Palao Guillermo, Gutiérrez-Cañas Irene, Ramírez Juan C, Arenzana-Seisdedos Fernando, Pablos José L

Primary Institution: Hospital 12 de Octubre, Madrid, Spain

Hypothesis

How does CXCL12 interact with endothelial cells in rheumatoid arthritis?

Conclusion

CXCL12 binds to heparan sulfate proteoglycans on endothelial cells in rheumatoid arthritis, which may enhance leukocyte recruitment and angiogenesis.

Supporting Evidence

  • CXCL12 was found in higher amounts on the endothelium of rheumatoid arthritis tissues compared to osteoarthritis.
  • The binding of CXCL12 to endothelial cells was shown to be independent of its receptor CXCR4.
  • Inflammatory cytokines increased the binding capacity of CXCL12 to endothelial cells.

Takeaway

In rheumatoid arthritis, a protein called CXCL12 sticks to the surface of blood vessel cells, helping white blood cells move into the inflamed area.

Methodology

The study involved analyzing the binding of CXCL12 to endothelial cells from rheumatoid arthritis and osteoarthritis tissues using flow cytometry and immunofluorescence.

Limitations

The study primarily focused on in vitro conditions and may not fully represent in vivo interactions.

Participant Demographics

Patients with rheumatoid arthritis and osteoarthritis undergoing joint replacement surgery.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/ar1900

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication